- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01177514
The Role of Gabapentin in Postoperative Pain and Epithelialization After Photorefractive Keratectomy
The Role of Gabapentin in Postoperative Pain and Epithelialization After Photorefractive Keratectomy A Prospective, Randomized, Double Blinded, Placebo Controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Baja California
-
Tijuana, Baja California, Mexico, 22320
- CODET Vision Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subjects must be at least 18 years of age
- Subjects must not have any corneal disease or degeneration
- Subjects must be candidates for LASIK or PRK refractive surgery
Exclusion Criteria:
- History of topical ocular medications within 4 weeks prior to enrollment
- History of conjunctivitis or ocular inflammation within 4 weeks prior to enrollment
- History of a previous refractive surgery
- History of previous diagnosis of corneal disease, degeneration, or glaucoma
- History of autoimmune disease
- History of oral anti-histamines currently or within 1 week of study enrollment
- History of systemic anti-inflammatory or pain medication currently or within 4 weeks of study enrollment
- Use of oral diuretics or betablocker currently or within 1 week of study enrollment
- Current diagnosis of dry eye
- Patients whose Best corrected vision is less than 20/20
- Patients whose target post operative refraction is not plano
- Pregnant and lactating
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: GABAPENTIN
Group of patients treated with oral gabapentin
|
Gabapentin PO. (300MG) 1 capsule the night before surgery, q12hrs the day of surgery and q8hrs for the firt 3 postoperative days.
|
|
Placebo Comparator: PLACEBO
Group given the placebo capsules
|
Sugar pill.
One capsule given the night before surgery, q12hrs on the day of surgery and q8hrs for the first 3 postoperative days.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain at moment of examination
Time Frame: 24 hours postoperatively
|
Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day |
24 hours postoperatively
|
|
Average pain for the previous 24 hour period,
Time Frame: assesed at 24 hours
|
Numerical visual scale questionnaire, a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded
|
assesed at 24 hours
|
|
Maximum pain intensity for the previous 24 hour period
Time Frame: Assesed at 24 hours postoperatively
|
In a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded.
|
Assesed at 24 hours postoperatively
|
|
Pain at moment of examination
Time Frame: 48 hours postoperatively
|
Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day |
48 hours postoperatively
|
|
pain on examination
Time Frame: 72 hours postoperatively
|
Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day |
72 hours postoperatively
|
|
pain on examination
Time Frame: 96 hours ostoiperatively
|
Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day |
96 hours ostoiperatively
|
|
Pain at moment of examination
Time Frame: postoperative day 7
|
Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day |
postoperative day 7
|
|
Average pain for the previous 24 hour period
Time Frame: Assesed at 48 hours
|
Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day |
Assesed at 48 hours
|
|
Average pain during the previous 24 hour period
Time Frame: Assesed at 72 hours postoperatively
|
Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day |
Assesed at 72 hours postoperatively
|
|
Average pain for the last 24 hours period
Time Frame: Assesed at 96 hours postoperatively
|
Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day |
Assesed at 96 hours postoperatively
|
|
Average pain since last examination
Time Frame: Assesed on postopertive day 7
|
Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day |
Assesed on postopertive day 7
|
|
Maximum pain intensity for the previous 24 hour period
Time Frame: Assesed at 48 hours postoperatively
|
Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day |
Assesed at 48 hours postoperatively
|
|
Maximum pain intensity for the previous 24 hour period
Time Frame: Assesed at 72 hours postoperatively
|
Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day |
Assesed at 72 hours postoperatively
|
|
Maximum pain intensity for the last 24 hour period
Time Frame: Assesed at 96 hours postoperatively
|
Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day |
Assesed at 96 hours postoperatively
|
|
Maximum pain intensity since the last examination
Time Frame: Assesed on the 7th postoperative day
|
Numerical Visual scale questionnaire. a scale from 0-10 where 0 is the least amount of pain and 10 being the most pain felt was recorded Every patient will be examined every 24 hours until complete healling which usualy takes place between 3 and 4 days; after complete healing the next and last examination is performed at the 7th postoperative day |
Assesed on the 7th postoperative day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time required for complete healing
Time Frame: Evaluated each day until complete healing
|
Slit lamp observation of the epithelial defect and time until removal of contact lens.
|
Evaluated each day until complete healing
|
|
Visual acuity
Time Frame: every day until complete healing and at the 7th day postop
|
Snellen Chart
|
every day until complete healing and at the 7th day postop
|
|
Foreign body sensation
Time Frame: Every 24 hours until complete healing and at the 7th day postop
|
Numerical visual scale, In a scale from 0-10 where 0 is the least amount of foreign body sensation and 10 being the most.
|
Every 24 hours until complete healing and at the 7th day postop
|
|
Light sensitivity
Time Frame: Every 24 hours until complete healing and at the 7th day postop
|
Numerical visual scale, in a scale from 0-10 where 0 is the least amount of light sensitibity and 10 being the most.
|
Every 24 hours until complete healing and at the 7th day postop
|
|
Tearing and watery eyes
Time Frame: Every 24 hours until complete healing and at the 7th day postop
|
Numerical visual scale questionaire, In a scale from 0-10 where 0 is the least amount of tearing and 10 being the most.
|
Every 24 hours until complete healing and at the 7th day postop
|
|
Eye discomfort
Time Frame: Every 24 hours until complete healing and at the 7th day postop
|
Numerical visual scale questionnaire, In a scale from 0-10 where 0 is the least amount of discomfort and 10 being the most.
|
Every 24 hours until complete healing and at the 7th day postop
|
|
Dizziness
Time Frame: Every 24 hours until complete healling and at the 7th day postop
|
Numerical visual scale, scale from 0-10 where 0 is the least dizzy and 10 being the most.
|
Every 24 hours until complete healling and at the 7th day postop
|
|
lethargy
Time Frame: Every 24 hours until complete healing and at the 7th day postop
|
Numerical visual scale, In a scale from 0-10 where 0 is the least lethargic and 10 is the most.
|
Every 24 hours until complete healing and at the 7th day postop
|
|
Headache
Time Frame: Every 24 hours until complete healing and at the 7th day postop
|
Numerical visual scale, In a scale from 0-10 where 0 is the least amount of headache and 10 being the most severe headache felt.
|
Every 24 hours until complete healing and at the 7th day postop
|
|
Gastro-intestinal symptoms
Time Frame: Every 24 hours until complete healing and at the 7th day postop
|
Numerical visual scale, In a scale from 0-10 where 0 is the least amount of symptoms and 10 being the most symptoms.
|
Every 24 hours until complete healing and at the 7th day postop
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Postoperative Complications
- Pain
- Neurologic Manifestations
- Pain, Postoperative
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Excitatory Amino Acid Antagonists
- Excitatory Amino Acid Agents
- Tranquilizing Agents
- Psychotropic Drugs
- Anti-Anxiety Agents
- Anticonvulsants
- Antimanic Agents
- Gabapentin
Other Study ID Numbers
- GABA1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain After Photorefractive Keratectomy
-
Assiut UniversityNot yet recruitingPhotorefractive Keratectomy
-
Assiut UniversityActive, not recruiting
-
Isfahan University of Medical SciencesIsfahan Ophthalmology Research CenterCompletedPhotorefractive KeratectomyIran, Islamic Republic of
-
University of UtahCompletedPhotorefractive KeratectomyUnited States
-
Assiut UniversityRecruitingCompare Corneal High Order Aberrations Before and After Stream Light Trans-PRK and Mechanical Photorefractive KeratectomyEgypt
-
Research Institute of Ophthalmology, EgyptRecruitingPain After Photorefractive Keratectomy | VAS Will be Used to Assess Pain PostoperativeEgypt
-
Eyegate Pharmaceuticals, Inc.CompletedRefractive Surgery | Ophthalmology | Photorefractive Keratectomy ("PRK") | Laser Assisted SurgeryUnited States
-
Merck Sharp & Dohme LLCTerminated
-
Laboratorios Sophia S.A de C.V.CompletedPhotorefractive Keratectomy | Corneal De-epithelializationMexico
-
Alcon ResearchMatthew CaldwellCompletedPhotorefractive KeratectomyUnited States
Clinical Trials on Gabapentin
-
University Hospital, GhentAmsterdam UMC, location VUmc; University GhentCompletedEpilepsy and Neuropathic PainBelgium
-
Samuel Lunenfeld Research Institute, Mount Sinai...Completed
-
Mayo ClinicCompleted
-
Viatris Specialty LLCCompletedAbuse PotentialUnited States
-
University of KarachiCenter for Bioequivalence Studies and Clinical Research; Merck Pvt. Ltd, PakistanCompletedHealthy Volunteers | Bioequivalence StudyPakistan
-
Indiana UniversityCompletedPostoperative PainUnited States
-
Ain Shams UniversityNot yet recruiting
-
Celgene CorporationCompletedBreast Neoplasms | Metastases, NeoplasmUnited States
-
Celgene CorporationCompletedNeoplasms | Metastases, NeoplasmUnited States
-
XenoPort, Inc.Completed